UnitedHealth Group Given Average Rating of “Buy” by Analysts (NYSE:UNH)
Shares of UnitedHealth Group (NYSE:UNH) have received an average rating of “Buy” from the twenty-four ratings firms that are currently covering the stock, AnalystRatings.Net reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $78.72.
Shares of UnitedHealth Group (NYSE:UNH) traded up 0.27% during mid-day trading on Friday, hitting $73.68. 1,372,514 shares of the company’s stock traded hands. UnitedHealth Group has a one year low of $52.51 and a one year high of $77.33. The stock’s 50-day moving average is $72.81 and its 200-day moving average is $72.33. The company has a market cap of $72.884 billion and a price-to-earnings ratio of 13.36.
UnitedHealth Group (NYSE:UNH) last released its earnings data on Wednesday, January 15th. The company reported $1.41 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.40 by $0.01. The company had revenue of $31.10 billion for the quarter, compared to the consensus estimate of $31.06 billion. During the same quarter in the prior year, the company posted $1.20 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. On average, analysts predict that UnitedHealth Group will post $5.59 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, March 25th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.52%.
In other UnitedHealth Group news, Director Gail Wilensky sold 21,100 shares of UnitedHealth Group stock on the open market in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $74.03, for a total transaction of $1,562,033.00. Following the sale, the director now directly owns 49,932 shares in the company, valued at approximately $3,696,466. The transaction was disclosed in a filing with the SEC, which is available at this link.
Several analysts have recently commented on the stock. Analysts at TheStreet reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, February 11th. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 22nd.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.